Medical technologies play a critical role in the prevention, diagnosis, and treatment of non-communicable diseases. Yet, despite the rising burden of such diseases in least-developed countries (LDCs), access to MedTech solutions is an issue in many LDCs.
In order to identify solutions, World Intellectual Property Organization – WIPO, the UN Technology Bank for the Least Developed Countries, and Medtronic have just published a joint study examining the current drivers of innovation and access in the MedTech sector for non-communicable diseases across LDCs.
The study looks at intellectual property (IP), regulation, financing, and capacity-building in the MedTech industry. Through in-depth case studies of Bangladesh and Rwanda, it provides insights into country-specific contexts while also reflecting broader regional perspectives.
By addressing challenges and opportunities, the study aims to inform strategies that will strengthen MedTech innovation and access, helping ensure that patients in LDCs benefit from the technologies they need. Below are some key takeaways from the study:
- MedTech is emerging as a leading sector in international patent filings via WIPO’s Patent Cooperation Treaty system. There are great opportunities to further strengthen IP systems by addressing filing costs, enhancing IP frameworks, and building IP awareness. Regulatory harmonization, innovative financing models, such as public-private partnerships and innovation funds, together with sustained investment in training, will continue unlocking MedTech growth.
- In a case study, the report shows the impact of reforms in Rwanda from community-based health insurance to updated IP laws and initiatives such as drone delivery and telemedicine. While most MedTech is still imported, regional trade incentives, evolving IP frameworks, and capacity building efforts are opening new opportunities.
-Bangladesh’s MedTech ecosystem is expanding, with a growing manufacturing base and even exports in certain product areas. Recent laws and guidelines have added regulatory clarity and boosted investment, while there is potential to streamline the approval processes and boost compliance capacity.
Strengthening IP awareness, regulatory systems, and local manufacturing through partnerships will be key to the next stage of growth for MedTech in a range of LDCs.
Find out the full report here: https://lnkd.in/em9n77uy
#WIPO #IP #GlobalHealth #NCDs #MedTech #Medtronic #UNTechnologyBank